BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35635715)

  • 1. HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner.
    Sorin S; Kubota S; Hamidi S; Yokomizo-Nakano T; Vaeteewoottacharn K; Wongkham S; Waraasawapati S; Pairojkul C; Bai J; Morii M; Sheng G; Sawanyawisuth K; Sashida G
    FASEB J; 2022 Jul; 36(7):e22345. PubMed ID: 35635715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.
    Techasen A; Namwat N; Loilome W; Bungkanjana P; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
    Med Oncol; 2012 Dec; 29(5):3083-91. PubMed ID: 22903530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
    Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J
    PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma.
    Lang Q; Xiao P; Zhao M; Liang D; Meng Q; Pei T
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1247-1256. PubMed ID: 33166992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells.
    Kwon RJ; Han ME; Kim JY; Liu L; Kim YH; Jung JS; Oh SO
    PLoS One; 2016; 11(11):e0165516. PubMed ID: 27835650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
    Yang J; Sontag D; Gong Y; Minuk GY
    Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
    Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma.
    Sato Y; Harada K; Itatsu K; Ikeda H; Kakuda Y; Shimomura S; Shan Ren X; Yoneda N; Sasaki M; Nakanuma Y
    Am J Pathol; 2010 Jul; 177(1):141-52. PubMed ID: 20489148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
    Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.
    Kongpetch S; Jusakul A; Ong CK; Lim WK; Rozen SG; Tan P; Teh BT
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):233-44. PubMed ID: 25966424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of the nucleosome-binding protein HMGN3 in mouse brain.
    Ito Y; Bustin M
    J Histochem Cytochem; 2002 Sep; 50(9):1273-5. PubMed ID: 12185205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of RIZ1 to regulation of proliferation and migration of a liver fluke-related cholangiocarcinoma cell.
    Khaenam P; Niibori A; Okada S; Jearanaikoon P; Araki N; Limpaiboon T
    Asian Pac J Cancer Prev; 2012; 13(8):4007-11. PubMed ID: 23098508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic and transcriptional alterations of cholangiocarcinoma.
    Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.